Faizan Farooque

Faizan Farooque

Expertise: Real estate investment trusts (REITs), SPACs, Cryptocurrencies

Education: BSc (Hons) Degree in Applied Accounting, Oxford Brookes University; Introduction to Data Analysis Using Excel, Rice University; Excel Skills for Business: Intermediate, Macquarie University

About Faizan
Faizan Farooque is a finance journalist who has reported on the latest trends in the stock market for many years. He helps people by providing advice about saving and investing and keeping up with what’s happening in the financial world.

Faizan is writing for InvestorPlace.com, GuruFocus, and TipRanks and has previously worked as a financial journalist and data analyst for S&P Global. He can analyze company filings from sources like SEC, FINRA, and others to help identify potential investment opportunities. Researching specific industries is also something he does to provide industry insight for clients.

Faizan deeply understands the market and how to read the financial tea leaves to anticipate where things are headed. His expertise gives readers an insider’s perspective on what’s happening in the finance world so they can make smart decisions.

Recent Articles

Here Are 7 Stocks to Avoid Snapping Up in August

Many of the biggest losers in 2021 enjoyed big runs last year. But keeping up with shifting trends, here are some popular stocks to avoid.

7 Strong Mega-Cap Stocks to Snap Up For Dividends and Growth

Mega-cap stocks are not as exciting as the latest growth plays, but they offer stable growth with minimal risk during times of volatility.

7 Popular Robinhood Stocks That Deserve a Place in Your Portfolio

Although often brushed aside for being meme stocks, these seven stocks popular on Robinhood are excellent picks for your portfolio.

5 Retail Stocks to Buy Ahead of Strong Back-to-School Sales

Back-to-school retail stocks are one of the more interesting ways to play the reopening trend after more than a year of virtual learning.

Clover Health Is a Good Way to Benefit From Meme-Stock Mania

CLOV stock doesn't have enough catalysts to be a long-term investment. But the name's high short interest should keep traders interested.